OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

被引:647
作者
Roth, Megan [1 ]
Obaidat, Amanda [1 ]
Hagenbuch, Bruno [1 ,2 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
[2] Univ Kansas, Ctr Canc, Kansas City, KS 66160 USA
基金
美国国家卫生研究院;
关键词
SLCO; SLC22A; OATP; OAT; OCT; drug transport; membrane transport; MESSENGER-RNA EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISMS; DRUG-DRUG INTERACTIONS; HIV PROTEASE INHIBITORS; EPIDERMAL-GROWTH-FACTOR; AMINO-ACID-RESIDUES; IN-VIVO EVIDENCE; HEPATIC-UPTAKE; FUNCTIONAL-CHARACTERIZATION; HUMAN LIVER;
D O I
10.1111/j.1476-5381.2011.01724.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The human organic anion and cation transporters are classified within two SLC superfamilies. Superfamily SLCO (formerly SLC21A) consists of organic anion transporting polypeptides (OATPs), while the organic anion transporters (OATs) and the organic cation transporters (OCTs) are classified in the SLC22A superfamily. Individual members of each superfamily are expressed in essentially every epithelium throughout the body, where they play a significant role in drug absorption, distribution and elimination. Substrates of OATPs are mainly large hydrophobic organic anions, while OATs transport smaller and more hydrophilic organic anions and OCTs transport organic cations. In addition to endogenous substrates, such as steroids, hormones and neurotransmitters, numerous drugs and other xenobiotics are transported by these proteins, including statins, antivirals, antibiotics and anticancer drugs. Expression of OATPs, OATs and OCTs can be regulated at the protein or transcriptional level and appears to vary within each family by both protein and tissue type. All three superfamilies consist of 12 transmembrane domain proteins that have intracellular termini. Although no crystal structures have yet been determined, combinations of homology modelling and mutation experiments have been used to explore the mechanism of substrate recognition and transport. Several polymorphisms identified in members of these superfamilies have been shown to affect pharmacokinetics of their drug substrates, confirming the importance of these drug transporters for efficient pharmacological therapy. This review, unlike other reviews that focus on a single transporter family, briefly summarizes the current knowledge of all the functionally characterized human organic anion and cation drug uptake transporters of the SLCO and the SLC22A superfamilies.
引用
收藏
页码:1260 / 1287
页数:28
相关论文
共 304 条
[1]
LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers [J].
Abe, T ;
Unno, M ;
Onogawa, T ;
Tokui, T ;
Kondo, TN ;
Nakagomi, R ;
Adachi, H ;
Fujiwara, K ;
Okabe, M ;
Suzuki, T ;
Nunoki, K ;
Sato, E ;
Kakyo, M ;
Nishio, T ;
Sugita, J ;
Asano, N ;
Tanemoto, M ;
Seki, M ;
Date, F ;
Ono, K ;
Kondo, Y ;
Shiiba, K ;
Suzuki, M ;
Ohtani, H ;
Shimosegawa, T ;
Iinuma, K ;
Nagura, H ;
Ito, S ;
Matsuno, S .
GASTROENTEROLOGY, 2001, 120 (07) :1689-1699
[2]
Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1 [J].
Abe, T ;
Kakyo, M ;
Tokui, T ;
Nakagomi, R ;
Nishio, T ;
Nakai, D ;
Nomura, H ;
Unno, M ;
Suzuki, M ;
Naitoh, T ;
Matsuno, S ;
Yawo, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17159-17163
[3]
Molecular characterization of human and rat organic anion transporter OATP-D [J].
Adachi, H ;
Suzuki, T ;
Abe, M ;
Asano, N ;
Mizutamari, H ;
Tanemoto, M ;
Nishio, T ;
Onogawa, T ;
Toyohara, T ;
Kasai, S ;
Satoh, F ;
Suzuki, M ;
Tokui, T ;
Unno, M ;
Shimosegawa, T ;
Matsuno, S ;
Ito, S ;
Abe, T .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (06) :F1188-F1197
[4]
PROLONGATION AND ENHANCEMENT OF SERUM METHOTREXATE CONCENTRATIONS BY PROBENECID [J].
AHERNE, GW ;
PIALL, E ;
MARKS, V ;
MOULD, G ;
WHITE, WF .
BRITISH MEDICAL JOURNAL, 1978, 1 (6120) :1097-1099
[5]
RADIOIMMUNOASSAY OF METHOTREXATE - USE OF SE-75-LABELED METHOTREXATE [J].
AHERNE, W ;
PIALL, E ;
MARKS, V .
ANNALS OF CLINICAL BIOCHEMISTRY, 1978, 15 (NOV) :331-334
[6]
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers [J].
Akamine, Yumiko ;
Miura, Masatomo ;
Sunagawa, Satoko ;
Kagaya, Hideaki ;
Yasui-Furukori, Norio ;
Uno, Tsukasa .
XENOBIOTICA, 2010, 40 (11) :782-789
[7]
Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites [J].
Alebouyeh, M ;
Takeda, M ;
Onozato, ML ;
Tojo, A ;
Noshiro, R ;
Hasannejad, H ;
Inatomi, J ;
Narikawa, S ;
Huang, XL ;
Khamdang, S ;
Anzai, N ;
Endou, H .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 93 (04) :430-436
[8]
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1 [J].
Annaert, P. ;
Ye, Z. W. ;
Stieger, B. ;
Augustijns, P. .
XENOBIOTICA, 2010, 40 (03) :163-176
[9]
New insights into renal transport of urate [J].
Anzai, Naohiko ;
Kanai, Yoshikatsu ;
Endou, Hitoshi .
CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (02) :151-157
[10]
Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells [J].
Asif, AR ;
Steffgen, J ;
Metten, M ;
Grunewald, RW ;
Müller, GA ;
Bahn, A ;
Burckhardt, G ;
Hagos, Y .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2005, 450 (02) :88-95